Cargando…

LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway

Lung adenocarcinoma (LAD) is one of the most common malignancies that threats human health worldwide. Long non-coding RNAs (lncRNAs) have been reported to play significant roles in tumorigenesis and might be novel biomarkers and targets for diagnosis and treatment of cancers. TP73-AS1 is a newly dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chunfeng, Ren, Lei, Deng, Jun, Wang, Songping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328885/ https://www.ncbi.nlm.nih.gov/pubmed/30541897 http://dx.doi.org/10.1042/BSR20180999

Ejemplares similares

LncRNA TP73-AS1 down-regulates miR-139-3p to promote retinoblastoma cell proliferation
por: Xia, Zhaoxia, et al.
Publicado: (2019)

The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
por: Mazor, Gal, et al.
Publicado: (2019)

LncRNA TP73-AS1 Activates TGF-β1 to Promote the Migration and Invasion of Colorectal Cancer Cell
por: Li, Mingli, et al.
Publicado: (2019)

Huaier Restrains Cholangiocarcinoma Progression in vitro and in vivo Through Modulating lncRNA TP73-AS1 and Inducing Oxidative Stress
por: Ji, Daolin, et al.
Publicado: (2020)

LncRNA TP73-AS1 Activates TGF-β1 to Promote the Migration and Invasion of Colorectal Cancer Cell [Corrigendum]
Publicado: (2020)

LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway
por: Tong, Chang-Jun, et al.
Publicado: (2021)

LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes
por: Yao, Hongchao, et al.
Publicado: (2022)

lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K/AKT pathway
por: Zhu, Kongxi, et al.
Publicado: (2019)

LncRNA TP73-AS1 interacted with miR-141-3p to promote the proliferation of non-small cell lung cancer
por: Liu, Xinfa, et al.
Publicado: (2019)

LncRNA LOXL1-AS1 Promotes the Proliferation and Metastasis of Medulloblastoma by Activating the PI3K/AKT Pathway
por: Gao, Ran, et al.
Publicado: (2018)

LncRNA TP73-AS1 promotes oxidized low-density lipoprotein-induced apoptosis of endothelial cells in atherosclerosis by targeting the miR-654-3p/AKT3 axis
por: Ni, Jia, et al.
Publicado: (2021)

Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
por: Yang, Dongyong, et al.
Publicado: (2021)

LncRNA TP73‐AS1 enhances the malignant properties of pancreatic ductal adenocarcinoma by increasing MMP14 expression through miRNA ‐200a sponging
por: Miao, Haiyan, et al.
Publicado: (2021)

LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis
por: Yao, Xinliang, et al.
Publicado: (2018)

LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter
por: Ni, Hongyan, et al.
Publicado: (2020)

LncRNA LASTR promote lung cancer progression through the miR-137/TGFA/PI3K/AKT axis through integration analysis
por: Xia, Manhui, et al.
Publicado: (2022)

LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
por: Huang, Yanxia, et al.
Publicado: (2017)

The Down-Regulation of lncRNA PCAT18 Promotes the Progression of Gastric Cancer via MiR-107/PTEN/PI3K/AKT Signaling Pathway
por: Chen, Ping, et al.
Publicado: (2019)

LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K/Akt/mTOR pathway
por: Qi, Fei, et al.
Publicado: (2023)

Exosomal lncRNA LINC01268 promotes pancreatic cancer progression via the miR-217-KIF2A-PI3K/AKT axis
por: Liu, Shanshan, et al.
Publicado: (2023)

LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA
por: Tang, Jianming, et al.
Publicado: (2018)

LncRNA‐LOC101928316 contributes to gastric cancer progression through regulating PI3K‐Akt‐mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2019)

Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway: CENPM promotes lung adenocarcinoma progression
por: Liu, Chao, et al.
Publicado: (2021)

Correction to: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
por: Huang, Yanxia, et al.
Publicado: (2020)

LncRNA TDRG1 Promotes Proliferation, Invasion and Epithelial-Mesenchymal Transformation of Osteosarcoma Through PI3K/AKT Signal Pathway
por: Huang, Yan, et al.
Publicado: (2020)

Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway
por: Chen, Xiaojun, et al.
Publicado: (2021)

Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021)

LncRNA TP73-AS1 sponges miR-141-3p to promote the migration and invasion of pancreatic cancer cells through the up-regulation of BDH2
por: Cui, Xian-Ping, et al.
Publicado: (2019)

LncRNA LINC00961 regulates endothelial-mesenchymal transition via the PTEN-PI3K-AKT pathway
por: Hu, Jin-Xing, et al.
Publicado: (2022)

Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2017)

LncRNA TBX5-AS1 Regulates the Tumor Progression Through the PI3K/AKT Pathway in Non-Small Cell Lung Cancer
por: Qu, Qing-hai, et al.
Publicado: (2020)

LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p
por: Wang, Zhen, et al.
Publicado: (2022)

LncRNA LINC01512 Promotes the Progression and Enhances Oncogenic Ability of Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2017)

LncRNA NCAL1 potentiates natural killer cell cytotoxicity through the Gab2-PI3K-AKT pathway
por: Niu, Chao, et al.
Publicado: (2022)

LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway
por: Dai, Qingqiang, et al.
Publicado: (2020)

N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway
por: Tan, Lei, et al.
Publicado: (2021)

LncRNA Bmp1 promotes the healing of intestinal mucosal lesions via the miR-128-3p/PHF6/PI3K/AKT pathway
por: Zhuang, Mengmeng, et al.
Publicado: (2021)

LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing
por: Chen, Qi Wen, et al.
Publicado: (2023)

A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway
por: Chen, Qi, et al.
Publicado: (2020)

lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells
por: Zhou, Fachen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dprue53id4bq290g9vtt08t8ma